IP Library › Patent Application 11462531
Patent Application
App. No. 11/462,531

Crystalline Form of Telmisartan Sodium

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/462,531
Abstract

The invention relates to a crystalline sodium salt of 4′-[2-n-propyl-4-methyl-6-(1-methyl-benzimidazol-2-yl)benzimidazol-1-ylmethyl]biphenyl-2-carboxylic acid (INN: telmisartan), processes for preparing it and the use thereof for preparing a pharmaceutical composition.

Claims (4)

1 . A compound of formula 2

wherein H—X denotes an acid selected from the group consisting of hydrochloric acid, hydrobromic acid, toluenesulphonic acid and methanesulphonic acid.

2 . The compound of formula 2 according to claim 1 , wherein H—X denotes hydrogen chloride.

3 . A compound according to claim 1 or claim 2 , in crystalline form.